Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Chula Vista, Calif.-based early phase CRO will undertake DiaVacs, a biotech company testing a Type I diabetes therapy in Phase Ib/IIa trials. The double-blind, placebo-controlled study will begin by first enrolling 10 subjects who are at least 18 years of age with newly diagnosed Type I diabetes (< 6 months from diagnosis). The 15-month study commitment will have the study participants visiting the Profil facility to test DiaVacs proprietary cell-based therapy. Profil specializes in diabetes and obesity trials.
Read the full release here.